2026, Volume 19, Issue 6, pp 492 – 495

Cerebrolysin as an adjunct to speech-language therapy in post-stroke Wernicke’s aphasia: a case report

Categories

Authors and Affiliations

* Corresponding author Marina Romano, Department of Neurology, CEMIC, Buenos Aires, Argentina; E-mail: [email protected]

Abstract

Post-stroke aphasia is a debilitating condition affecting approximately one-third of stroke survivors, profoundly impairing communication, social participation, and quality of life. While speech-language therapy (SLT) remains the standard of care, pharmacological agents such as Cerebrolysin may enhance recovery through neuroprotection and neuroplasticity. We report the case of a 38-year-old female lawyer who developed acute Wernicke’s aphasia and right-sided hemiparesis following an ischemic stroke. Despite timely thrombolysis and mechanical thrombectomy, she experienced significant neurological deficits. Early multidisciplinary rehabilitation, combined with a 10-day course of Cerebrolysin, memantine, and sertraline, was associated with substantial improvements in language, motor function, and independence over a three-month period. This case highlights the potential synergistic effect of Cerebrolysin in a young patient with early reperfusion and intensive rehabilitation, including pharmacotherapy and SLT, especially in settings where optimal post-stroke rehabilitation resources may be limited.

Keywords

About this article

PMC ID: 
PubMed ID: 42602663
DOI: 10.25122/jml-2026-0057

Article Publishing Date (print):
Available Online: 

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.

Categories